CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II-Reference-Cited by-同舟云学术

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II

Published:2018-12-18 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

van Balen Peter,van Bergen Cornelis A. M.,van Luxemburg-Heijs Simone A. P.,de Klerk Wendy,van Egmond Esther H. M.,Veld Sabrina A. J.,Halkes Constantijn J. M.,Zwaginga Jaap-Jan,Griffioen Marieke,Jedema Inge,Falkenburg J. H. Frederik

Funder

KWF Kankerbestrijding

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation;Pasquini;J Clin Oncol,2012

2. Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission;Bayraktar;Biol Blood Marrow Trans.,2013

3. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation;Kottaridis;Blood,2000

4. Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath “in the bag” as T-cell depletion: the Leiden experience;Barge;Bone Marrow Transp,2006

5. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution;Chakrabarti;Blood,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minor histocompatibility antigens to predict, monitor or manipulate GvL and GvHD after allogeneic hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-06

2. Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens;Blood;2024-05-02

3. CD28null T cells in aging and diseases: From biology to assessment and intervention;International Immunopharmacology;2024-04

4. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

5. Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML;Frontiers in Immunology;2023-08-15